Cabozantinib is also used to treat liver cancer in people who have been previously treated with sorafenib. It can also block a chemical on tumor cells that allows the cells to grow. Cabometyx is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma rcc who have received prior anti angiogenic therapy. Although patients with thyroid cancer generally fare well, there is a subset for which this is not necessarily true. Cabometyx cabozantinib is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib. However, studies have shown that prostate and ovarian tumors respond to it. Researchers want see if cabozantinib can be a safe and effective treatment for urothelial cancer. Cabozantinib cabozantinib capsules are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. A similar drug, pazopanib, is used to treat types of cancer known as sarcomas. Highlights of prescribing information palmarplantar. Cabozantinib cometriq is recommended, within its marketing authorisation, as an option for treating progressive medullary thyroid cancer in adults with unresectable, locally advanced or metastatic disease, only if the manufacturer provides cabozantinib with the discount agreed in the patient access scheme. The sequence that cabozantinib should be used among the growing number of therapeutic options is also up for investigation. Severe and fatal hemorrhages occurred with cabometyx.
Do not exceed a daily dose of 80 mg see drug interactions 7. Highlights of prescribing information these highlights do not include all the information needed to use votrient safely and effectively. Votrient pazopanib tablets, for oral use initial u. Fda approves cabozantinib for renal cell carcinoma. Dosageadministration indication dose thyroid carcinoma, nonsmall cell lung cancer nsclc cometriq 140 mg orally once daily capsule formulation. The printed package leaflet of the medicinal product must state the name and.
Cometriq, cabometyx cabozantinib dosing, indications. The us fda recently gave cabozantinib the nod as the firstline treatment fo. Feb 11, 2020 cometriq cabozantinib capsules for oral use are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. Cabozantinib for previously treated advanced renal cell.
Cabozantinib could be firstline choice in advanced rcc. Cabozantinib cometriq is used to treat a certain type of thyroid cancer that is getting worse and that has spread to other parts of the body. Sep 23, 2016 the sequence that cabozantinib should be used among the growing number of therapeutic options is also up for investigation. The incidence of grade 3 to 5 hemorrhagic events was 5% in cabometyx.
Product identifier product name cabozantinib malate biox product number fc64967. Do not substitute cometriq capsules with cabozantinib tablets. Cabozantinib for adults with advanced soft tissue sarcoma. It is a small molecule inhibitor of the tyrosine kinases cmet and vegfr2, and also inhibits axl and ret.
Cabozantinib is distinct from other approved treatment options, as it targets multiple tyrosine kinases involved in the development of rcc, including met, axl, and three vegf receptors. Tell your healthcare provider right away if you have rashes, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet. Overview cabozantinib for previously treated advanced renal. Coadministration of strong cyp3a4 inhibitors can increase cabozantinib exposure 2. Cabozantinib for advanced urothelial cancer full text view. Protein in your urine and possible kidney problems. Ipsen receives validation from european medicines agency for the application of a new indication for cabometyx cabozantinib for firstline treatment of advanced renal cell carcinoma in adults. Cabozantinib for advanced urothelial cancer full text. The materials available here for download can provide you with additional information about cometriq in pdf format so that you can easily save them or print them out. Rcc who have received prior antiangiogenic therapy. Cabometyx, inncabozantinib european medicines agency.
Your healthcare provider should tell you when you may start taking cabometyx again after surgery. Cabozantinib is a cancer treatment drug that blocks the growth of new blood vessels in tumors. Cabometyx is indicated for the treatment of patients with advanced renal cell carcinoma. Cabozantinib versus everolimus in advanced renalcell. Read how cabometyx cabozantinib may help those with advanced kidney cancer and liver cancer. This brochure provides an overview of treatment with cometriq. Length of authorization coverage will be provided for six months and may be renewed. Final appraisal determination cabozantinib for previously treated advanced renal cell carcinoma issue date. Provides access to the latest drug monographs submitted to the food and drug administration fda. If you miss a dose of cabozantinib, only take the missed dose if it has been less than 12 hours since you were supposed to take it. Cometriq cabozantinib capsules are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. Xelodawarfarin interaction xeloda warfarin interaction. Dailymed cometriq cabozantinib kit cometriq cabozantinib.
Prior to tasigna administration and periodically, monitor for hypokalemia or hypomagnesemia and correct deficiencies. Coronavirus covid19 update at exelixis, we remain committed to serving the needs of people who take cabometyx. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. No specific dose adjustment for the use of cabozantinib in older people. Cabozantinib may also be used for purposes not listed in this medication guide. Dec 25, 2017 cabozantinib was previously approved to treat advanced renal cell carcinoma as well as progressive medullary thyroid cancer.
Highlights of prescribing information these highlights do not. Cabozantinib is used to treat advanced kidney cancer, or thyroid cancer that has spread to other parts of the body. Do not substitute cabometyx tablets with cabozantinib capsules. Administer at least 1 hour before or at least 2 hours after eating see clinical pharmacology 12. Cabozantinib is used to treat advanced kidney cancer, or thyroid cancer that has spread to other parts of the body cabozantinib is also used to treat liver cancer in people who have been previously treated with sorafenib cabozantinib may also be used for purposes not listed in this medication guide. Dosage modifications for patients with moderate and severe. If strong cyp3a4 inhibitor required, decrease cabozantinib dose by 20 mgday eg, from 60 mg to 40 mg qday resume previous dose 23 days after strong cyp3a4 inhibitor discontinued. Cabozantinib cometriq is in a class of medications called tyrosine kinase inhibitors.
Cabometyx is a cancer medicine that contains the active substance cabozantinib. Identification of the substancemixture and of the companyundertaking 1. If strong cyp3a4 inhibitor required, decrease cabozantinib dose by 40 mgday eg, from 140 mg to 100 mg qday cabometyx. Though cabozantinibs approval was based on patients with advanced rcc who had received prior antiangiogenic therapy, there may be a role for the drug in treatmentnaive patients as a firstline therapy. Cabozantinib is a receptor tyrosine kinase inhibitor with activity against met, vegfr2, flt3, ckit, and ret. Common side effects of both cabozantinib and lenvatinib included fatigue, nausea, diarrhea, and hypertension. Cabozantinib should be taken whole and not crushed, cut, or dissolved. Mar 02, 2019 cabozantinib comes with a patient information insert. Highlights of prescribing information tafinlar with. If you miss a dose of cabozantinib, only take the missed dose if it has been less than 12. The oral tyrosine kinase inhibitor cabozantinib significantly improved progressionfree survival over standardofcare sunitinib in patients with metastatic renal cell carcinoma.
Wound healing problems have happened in some people who take cabometyx. Cabometyx cabozantinib tablets for oral use are supplied as filmcoated tablets containing 20 mg, 40 mg, or 60 mg of cabozantinib, which is equivalent to 25 mg, 51 mg, or 76 mg of cabozantinib smalate, respectively. The reporting of meteor coincided with that of the checkmate 025 study which randomized similarly eligible patients to receive nivolumab or everolimus 10 mg daily. Cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Among patients treated with cabozantinib, 60% had to have their dose decreased during the trial. Capsule slowrelease cardizem diltiazem tablet note.
Cabozantinib for previously treated advanced renal cell carcinoma. Nov 29, 2018 cabozantinib should be taken whole and not crushed, cut, or dissolved. Commission regulation eu no 2015830 of 28 may 2015. Exelixis announces fda approval of cabometyx cabozantinib.
See full prescribing information for complete boxed warning. Cabozantinib is a drug that slows the growth of blood vessels that feed tumors. See 17 for patient counseling information and fda approved patient. Clinical use of cabozantinib in the treatment of advanced. Restricted access do not disseminate or copy without approval. In postgemcitabine metastatic pancreatic cancer, consider a category 1 recommendation. Highlights of prescribing information when administering. As the drug development has occurred in parallel for cabozantinib and nivolumab, no evidence exists for decision making regarding optimal sequencing of these agents. Cabozantinib and lenvatinib for kidney cancer national. Sep 20, 2012 cabozantinib is a drug that slows the growth of blood vessels that feed tumors. You should stop taking cabometyx at least 3 weeks before planned surgery. Cometriq cabozantinib capsules for oral use are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. Cabozantinib comes with a patient information insert.
June 2017 2 the technology description of the technology cabozantinib cabometyx, ipsen is a small molecule that inhibits multiple receptor tyrosine kinases. Cabozantinib is an inhibitor of multiple receptor tyrosine kinases rtks including axl, flt3, kit. Patients receiving concomitant capecitabine and oral coumarin. Cabozantinib is an oral, smallmolecule inhibitor of tyrosine kinases, including met, vegf receptors vegfrs, and axl, and is currently approved for the treatment of patients with progressive. Cabozantinib, sold under the brandname cabometyx and cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. Hepatotoxicity see full prescribing information for complete boxed warning. Withhold cabozantinib for grade 4 diarrhea, grade 3 diarrhea that cannot be managed with standard antidiarrheal therapy, or for intolerable grade 2 diarrhea. Reduce the dosage of cabometyx if concomitant use with strong cyp3a4 inhibitors cannot be.
Jan 25, 2019 cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Evidencebased recommendations on cabozantinib cabometyx for previously treated advance renal cell carcinoma kidney cancer in adults. Cabozantinib is associated with a moderate emetic potential. Tell your healthcare provider if you plan to have any surgery before or during treatment with cabometyx. Cabometyx cabozantinib is indicated for the treatment of patients with advanced renal cell carcinoma rcc. If you are using this medication for thyroid cancer, read the monograph entitled cabozantinib thyroid cancer. The recommended daily dose of cabometyx cabozantinib is 60 mg. Cabometyx prior auth criteria proprietary information. Cabozantinib is also available as a capsule cometriq to treat a certain type of thyroid cancer. This monograph only gives information about cabozantinib tablets cabometyx for advanced rcc. Advanced stages of a type of kidney cancer called renal cell. Background renal cell carcinoma rcc is the most common form of kidney cancer and the eighth most common cancer in adults worldwide1 rcc commonly metastasizes to the brain, liver, lungs, lymph nodes, and bone. Safety data sheet cabozantinib malate biox according to regulation ec no 19072006, annex ii, as amended.
Feb 14, 2020 cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Highlights of prescribing information the recommended dose. Highlights of prescribing information these highlights do. Cabozantinib strongly binds to and inhibits several rtks, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor met, ret rearranged during transfection, vascular endothelial growth factor receptor.
Ipsen receives validation from european medicines agency for. Ipsen receives validation from european medicines agency. Activity of cabozantinib toward a broad range of tumor models could be detected in. Youll learn what cometriq is, how it can help, and how to take it. Do not take a missed dose within 12 hours of the next dose. Marketing authorisation cabozantinib is indicated for the treatment of. Chronic coadministration of strong cyp3a4 inducers can reduce cabozantinib exposure.
129 232 1222 396 633 583 6 503 720 463 266 834 719 709 804 962 1050 897 1384 291 1066 879 931 807 49 1002 353 270 842 166 1001 931 891